IMC Chicago’s iPath Series B S&P 500 VIX Mid-Term Futures ETN VXZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
25,500
+1,100
+5% +$60.8K ﹤0.01% 2834
2025
Q4
$1.31M Sell
24,400
-32,300
-57% -$1.81M ﹤0.01% 2767
2025
Q3
$3.14M Sell
56,700
-15,500
-21% -$892K ﹤0.01% 1925
2025
Q2
$4.22M Sell
72,200
-21,900
-23% -$1.32M ﹤0.01% 1501
2025
Q1
$5.19M Buy
+94,100
New +$4.91M ﹤0.01% 1210

Other funds holding VXZ

IMC Chicago's VXZ Position: Q3 2025 in Review

IMC Chicago sold out of iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) in Q3 2025, closing a stake of 67,341 shares — an estimated $3.88M sold.

IMC Chicago first reported a position in VXZ in Q4 2019 and held it in 13 quarters. The position peaked at $5.96M in Q2 2022. 8 funds tracked by Wall St. Rank hold VXZ as of Q3 2025.

  • IMC Chicago reported no remaining iPath Series B S&P 500 VIX Mid-Term Futures ETN position as of Q3 2025 after selling out during the quarter.
  • IMC Chicago sold 67,341 iPath Series B S&P 500 VIX Mid-Term Futures ETN shares in Q3 2025, an estimated $3.88M.
  • IMC Chicago first reported a position in iPath Series B S&P 500 VIX Mid-Term Futures ETN in Q4 2019 and held it in 13 quarters.
  • IMC Chicago's iPath Series B S&P 500 VIX Mid-Term Futures ETN position peaked at $5.96M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Mid-Term Futures ETN as of Q3 2025.

Based on IMC Chicago's 13F filing for Q3 2025, filed 4 Nov 2025.